Statement of Cash FlowsIndirect Method

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

		Dec. 31, 20Y3		Dec. 31, 20Y2
Assets
Cash		$311,440		$288,710
Accounts receivable (net)		112,820		103,690
Inventories		318,490		307,000
Investments		0		118,940
Land		163,360		0
Equipment		351,400		271,430
Accumulated depreciationequipment		(82,270)		(73,190)
	Total assets	$1,175,240		$1,016,580
Liabilities and Stockholders' Equity
Accounts payable (merchandise creditors)		$212,720		$200,270
Accrued expenses payable (operating expenses)		21,150		26,430
Dividends payable		11,750		9,150
Common stock, $10 par		63,460		49,810
Paid-in capital: Excess of issue price over par-common stock		238,570		138,250
Retained earnings		627,590		592,670
	Total liabilities and stockholders equity	$1,175,240		$1,016,580

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

The investments were sold for $139,160 cash.

Equipment and land were acquired for cash.

There were no disposals of equipment during the year.

The common stock was issued for cash.

There was a $82,700 credit to Retained Earnings for net income.

There was a $47,780 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.
Statement of Cash Flows
For the Year Ended December 31, 20Y3
Cash flows from operating activities:
	$
Adjustments to reconcile net income to net cash flow from operating activities:
Changes in current operating assets and liabilities:
Net cash flow from operating activities		$
Cash flows from investing activities:
	$
Net cash flow used for investing activities
Cash flows from financing activities:
	$
Net cash flow from financing activities
		$
Cash at the beginning of the year
Cash at the end of the year		$